Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy
Authors
Keywords
-
Journal
ARTHRITIS AND RHEUMATISM
Volume 64, Issue 10, Pages 3129-3138
Publisher
Wiley
Online
2012-10-01
DOI
10.1002/art.34565
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-17 and Th17 cells in tuberculosis
- (2010) Egídio Torrado et al. CYTOKINE & GROWTH FACTOR REVIEWS
- RORC2 Is Involved in T Cell Polarization through Interaction with the FOXP3 Promoter
- (2010) S. Burgler et al. JOURNAL OF IMMUNOLOGY
- Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells
- (2010) A. M. Thornton et al. JOURNAL OF IMMUNOLOGY
- Essential Role of IL-17A in the Formation of a Mycobacterial Infection-Induced Granuloma in the Lung
- (2010) Y. Okamoto Yoshida et al. JOURNAL OF IMMUNOLOGY
- Benefits 8 years after a remission induction regime with an infliximab and methotrexate combination in early rheumatoid arthritis
- (2010) V. Bejarano et al. RHEUMATOLOGY
- The effectiveness of anti-TNF- therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis
- (2010) S. Lloyd et al. RHEUMATOLOGY
- Protein Kinase C- Mediates Negative Feedback on Regulatory T Cell Function
- (2010) A. Zanin-Zhorov et al. SCIENCE
- Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis
- (2009) Hui Shen et al. ARTHRITIS AND RHEUMATISM
- Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry
- (2009) F. Tubach et al. ARTHRITIS AND RHEUMATISM
- IL-17-producing human peripheral regulatory T cells retain suppressive function
- (2009) G. Beriou et al. BLOOD
- IL-1β and IL-2 convert human Treg into TH17 cells
- (2009) Florence Deknuydt et al. CLINICAL IMMUNOLOGY
- Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor ROR t
- (2009) M. Ayyoub et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of IL-17-producing FOXP3+ regulatory T cells in humans
- (2009) K. S. Voo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-α, Oncostatin M and response to biologic therapies
- (2009) Ellen M Moran et al. ARTHRITIS RESEARCH & THERAPY
- Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells
- (2008) H. J. P. M. Koenen et al. BLOOD
- Foxp3 Inhibits RORγt-mediatedIL-17AmRNA Transcription through Direct Interaction with RORγt
- (2008) Kenji Ichiyama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
- (2008) Liang Zhou et al. NATURE
- IL-21 and TGF-β are required for differentiation of human TH17 cells
- (2008) Li Yang et al. NATURE
- Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis
- (2008) F. Flores-Borja et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of IL-17 production in human lymphocytes
- (2007) Zhi Chen et al. CYTOKINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started